New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
10:08 EDTCVSCVS Caremark sees 2014 share repurchases of $4B
CVS says that it is "well-positioned" for growth in a changing health care landscape. Says increased Medicaid enrollment will fuel its leading position in managed Medicaid. Sees 43M people enrolled in Medicaid enrollment by 2016. Says "well-positioned" to gain share in exchanges across the enterprise. Says overall growth in exchanges will be a net positive. Says focused on enhancing shareholder value through driving long-term growth, generating "significant" free cash flow and optimizing capital allocation. In terms of CAGR from FY13-FY18, CVS sees net revenue 9%-13%, sees operating profit 7%-9%, sees final adjusted EPS 10%-14%, sees share repurchase contribution 4%-6% and average annual cash available for enhancing shareholder value $7.5B-$8.5B. When discussing efficient cash deployment from FY14 through FY18, CVS says it will have $40B in cash available for enhancing shareholder value. Expects a target payout ratio for dividends during that time to be 35% by FY18 with 18% implied dividend CAGR. Expects a return on invested capital and says that it will drive ROIC with value-enhancing projects. Sees $4B-$5B of share repurchases per year through 2018. Comments taken from slides from CVS Caremark's presentation at the Wells Fargo Healthcare conference.
News For CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 7, 2015
09:02 EDTCVSBarclays to hold a symposium
Barclays Select Series: Biosimilars Symposium is being held in New York on October 7.
October 5, 2015
10:02 EDTCVSBofa/Merrill healthcare analysts hold an analyst/industry conference call
Subscribe for More Information
October 2, 2015
08:21 EDTCVSAmazon to be number two player in U.S. consumables by 2018, says Cowen
John Blackledge and the research team at Cowen project that (AMZN) will grow to be the number two player in the $425B market for U.S. consumables - which they define as personal care, household, pet and baby products - by 2018. The firm expects Amazon to use its multi-platform approach, centered around Prime, to help the e-commerce giant gain share in consumables at the expense of Wal-Mart (WMT), Target (TGT), Walgreens (WBA) and CVS Health (CVS). Cowen has Outperform ratings on Amazon and Target and a Market Perform rating on shares of Wal-Mart.
October 1, 2015
10:50 EDTCVSLeerink healthcare services analyst holds analyst/industry conference call
Analyst Larsen, along with Dan Steiber of D2 Pharma Consulting and James Kenney, Jr., of Harvard Pilgrim Health Care, discuss Hillary Care's potential impact to the Prescription Drug Supply Chain, the impact of the Medicaid rebate program and the uptake of bio-similars and generic launches in 2015 on an Analyst/Industry conference call to be held on October 2 at 12 pm.
September 30, 2015
10:47 EDTCVSLeerink analyst/industry conference call date/time changed from October 8 10 am
Healthcare Distribution & Technology Larsen, along with Diplomat Pharmacy Chairman & CEO Hagerman and CFO & Secretary/Treasurer Whelan, provide industry insights including the potential impact of Hillary Care, the influence CMS may have on overall drug pricing and recent stock volatility on an Analyst/Industry conference call now being held at a new date and time of September 30 at 5 pm.
09:05 EDTCVSCVS Health announces partnership with MassChallenge and Rock Health
CVS Health announced that it was partnering with top startup accelerator MassChallenge and digital health venture fund Rock Health to drive faster innovation and expand areas of focus for connected health solutions.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use